Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Epstein

Showing results (441-450 of 635) with videos related to

Pageof 64
Sort By:
The Journal of Urology|November 21, 2017
Incidence of Extraprostatic Extension at Radical Prostatectomy with Pure Gleason Score 3 + 3 = 6 (Grade Group 1) Cancer: Implications for Whether Gleason Score 6 Prostate Cancer Should be Renamed "Not Cancer" and for Selection Criteria for Active SurveillanceOudai Hassan, Misop Han, Amy Zhou, et al.
The Prostate|December 19, 2007
Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intentDanil V Makarov, Cameron Marlow, Jonathan I Epstein, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 11, 2012
Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasiaTamara L Lotan, Berrak Gumuskaya, Hameed Rahimi, et al.
Archives of Pathology & Laboratory Medicine|January 13, 2024
Metastatic Pleomorphic Lobular Carcinoma of the Breast to the Urinary Bladder: A Report of 10 Cases and Assessment of TRPS1 in the Differential Diagnosis With Plasmacytoid Urothelial CarcinomaGuan-Nan Zhang, Barbara Susnik, Emma J Paulsen, et al.
BJU International|July 30, 2016
Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillanceMufaddal M Mamawala, Karthik Rao, Patricia Landis, et al.
Journal of Computer Assisted Tomography|August 26, 2016
Computed Tomography Appearance of Surgically Resected Adrenal HematomasSteven P Rowe, Aarti Mathur, Justin A Bishop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Active surveillance program for prostate cancer: an update of the Johns Hopkins experienceJeffrey J Tosoian, Bruce J Trock, Patricia Landis, et al.
Human Pathology|April 26, 2015
Smooth muscle and adenoma-like renal tumor: a previously unreported variant of mixed epithelial stromal tumor or a distinctive renal neoplasm?Nathaniel E Smith, Jonathan I Epstein, Anil V Parwani, et al.
European Urology|January 11, 2020
Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective CohortJeffrey J Tosoian, Mufaddal Mamawala, Jonathan I Epstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance programAshley E Ross, Stacy Loeb, Patricia Landis, et al.
Pageof 64

Showing results (441-450 of 635) with videos related to

Sort By:
Pageof 64
The Journal of Urology|November 21, 2017
Incidence of Extraprostatic Extension at Radical Prostatectomy with Pure Gleason Score 3 + 3 = 6 (Grade Group 1) Cancer: Implications for Whether Gleason Score 6 Prostate Cancer Should be Renamed "Not Cancer" and for Selection Criteria for Active SurveillanceOudai Hassan, Misop Han, Amy Zhou, et al.
The Prostate|December 19, 2007
Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intentDanil V Makarov, Cameron Marlow, Jonathan I Epstein, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 11, 2012
Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasiaTamara L Lotan, Berrak Gumuskaya, Hameed Rahimi, et al.
Archives of Pathology & Laboratory Medicine|January 13, 2024
Metastatic Pleomorphic Lobular Carcinoma of the Breast to the Urinary Bladder: A Report of 10 Cases and Assessment of TRPS1 in the Differential Diagnosis With Plasmacytoid Urothelial CarcinomaGuan-Nan Zhang, Barbara Susnik, Emma J Paulsen, et al.
BJU International|July 30, 2016
Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillanceMufaddal M Mamawala, Karthik Rao, Patricia Landis, et al.
Journal of Computer Assisted Tomography|August 26, 2016
Computed Tomography Appearance of Surgically Resected Adrenal HematomasSteven P Rowe, Aarti Mathur, Justin A Bishop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Active surveillance program for prostate cancer: an update of the Johns Hopkins experienceJeffrey J Tosoian, Bruce J Trock, Patricia Landis, et al.
Human Pathology|April 26, 2015
Smooth muscle and adenoma-like renal tumor: a previously unreported variant of mixed epithelial stromal tumor or a distinctive renal neoplasm?Nathaniel E Smith, Jonathan I Epstein, Anil V Parwani, et al.
European Urology|January 11, 2020
Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective CohortJeffrey J Tosoian, Mufaddal Mamawala, Jonathan I Epstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance programAshley E Ross, Stacy Loeb, Patricia Landis, et al.
Pageof 64